Access links:
Access links:

The IrsiCaixa AIDS Research Institute is presenting, together with “la Caixa” Foundation, a scientific dissemination and prevention program on AIDS aimed at secondary school students, which is...
The Catalan Program for AIDS Vaccine Research, HIVACAT, has been selected to host AIDS Vaccine 2013, the largest and most prestigious international congress focusing exclusively on HIV vaccine...

The IrsiCaixa Institute for AIDS Research and the Autonomous University of Barcelona (UAB) have reached an agreement to cooperate with Harvard University Medical School of Boston, the Harvard...
HIVACAT has identified several protein fragments with high potential to stimulate an effective immune response against HIV.This finding has required studies in over 1,000 patients and has allowed...

IrsiCaixa researchers have analyzed the complete genome of more than 60 people infected with the AIDS virus and have identified 6 key genes that predict how the infection will progress in each...
Researchers from the IrsiCaixa Institute for AIDS Research, driven by the Social Program of "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya, have identified a...
A study published in the online edition of the journal The Lancet finds that 12% of children with HIV in Europe develop a triple virological failure. The study, led by the Medical Research Council...
Researchers at IrsiCaixa AIDS Research Institute participated in a study showing that some HIV-positive people have drug-resistant HIV minority variants which are not detectable with regular...
Normal 0 21 false false false MicrosoftInternetExplorer4 Researcher Julia G Prado travels to the city of Durban to apply current knowledge on HIV to virus subtype C IrsiCaixa’s...